Neuron23
South San Francisco, CA
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
neuron23.comCompany Details
Founded
- 2018
Employees
- Between 50 - 100 employees
Raised
- $213,500,000
Headquarters Location
- South San Francisco, CA
Public
- No
Acquired
- No
CEO
Nancy Stagliano
Founders
- Adam Knight
Company Collections
These are collections Neuron23 is a part of. Click on the collection name to view similar companies.